Skip to content

Sevofluran And IsoFluran Exposure Assessment In the Recovery room

Sevofluran And IsoFluran Exposure Assessment In the Recovery room - SAFEAIR

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00035076
Enrollment
13
Registered
2024-09-23
Start date
2024-09-12
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exposure of recovery room staff to the inhaled anesthetics caused by the exhalation of inhaled anesthetic gas from patients after surgery.

Interventions

Group 1: Human biomonitoring of employees (medical and nursing staff in the recovery room of the central operating theater of the University Hospital Bonn) with regard to exposure to the inhalation an

Sponsors

Zentralinstitut für Arbeitsmedizin und Maritime Medizin (ZfAM) Universitätsklinikum Hamburg-Eppendorf
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Age =18 years - Exposure to sevoflurane and isoflurane through occupational activity in the recovery room - Physicians or nursing staff of the UKB

Exclusion criteria

Exclusion criteria: - Age < 18 years - No informed consent of the staff member

Design outcomes

Primary

MeasureTime frame
The primary objective is to assess the internal exposure of recovery room staff to inhalation anesthetics (sevoflurane, isoflurane) in a quantified way using biomonitoring.

Secondary

MeasureTime frame
The secondary objective is the simultaneous assessment of external exposure to inhalation anesthetics (sevoflurane, isoflurane) by measuring room air concentrations in the recovery room.

Countries

Germany

Contacts

Public ContactMaria Wittmann

Klinik für Anästhesiologie und Operative Intensivmedizin Universitätsklinikum Bonn

maria.wittmann@ukbonn.de+49 22828714134

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026